Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

PRO.MED.CS Praha

PRO.MED.CS Praha a.s. is a Czech pharmaceutical Company located in Prague specialising in the manufacture of solid medicinal forms – tablets, film coated tablets and capsules. Our medicinal portfolio is primarily aimed at the cardiovascular, gastrointestinal and musculoskeletal areas and pain. We also provide medicines for mental disorders, bacterial and viral diseases. In addition to prescription medicines we produce over the counter medicines and trace elements too.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

PRO.MED.CS Praha
Telcska 1, Prague, 140 00, Czech Republic
+420 241 013 111
Contact PRO.MED.CS Praha
Website

 Latest Content from PMHub 

CHASE MedTech Outsourcing Solutions

Videos and Podcasts | July 19, 2023 | CHASE

Are you looking for a fast, flexible and affordable solution to your MedTech sales team? Get in touch today to find out how we can help https://lnkd.in/enFTdm6R

CHASE Nurses

Videos and Podcasts | July 19, 2023 | CHASE

Are you currently looking for a new nursing role? Want a work-life balance and continuous learning and development? Check out our exciting nursing roles here: https://lnkd.in/eZVGM7N3Talk to our colleague Victoria Henderson today...

Case study: How segmentation of treaters guided a novel product launch in the allergy space

White Papers and Resources | July 17, 2023 | Inizio

Find out how we helped our client to obtain an intuitive and actionable segmentation in order to drive market shaping activities ahead of their product launch aimed at the treatment...

Medscape Medical Affairs celebrate a double win at the Communiqué Awards 2023

Press Releases | July 14, 2023 | Medscape Medical Affairs

Medscape Medical Affairs celebrates a remarkable achievement with a double win at the prestigious Communiqué Awards 2023.

The 7 truths behind successful Healthcare influencer engagement programmes

White Papers and Resources | July 13, 2023 | Say Communications

Pharma companies need to be engaging DOLs in the same way as Key Opinion Leaders (KOLs). But how can companies ensure best practice DOL engagement? Here are Say’s recommended critical...

Mobilizing Agitation Detection in Children with ADHD

Videos and Podcasts | July 13, 2023 | Impetus Digital

Marius Rus, founder of StressLess–the startup behind Tully–discusses wearable technologies for children with ADHD, autism, and other mental health conditions. He also shares his tips and lessons learned from founding...

Article: War in the Blood – The battle takes shape in the burgeoning European oncology CAR-T market access space

White Papers and Resources | July 13, 2023 | Inizio

Tania Rodrigues investigates the market access and commercialization potential for manufacturers of CAR-T therapies in the latest issue of pharmaphorum's Deep Dive.

Say wins Communiqué Awards for corporate influencer campaign based on life hacks

White Papers and Resources | July 12, 2023 | Say Communications

SAY received the top recognition for the ‘Excellence in Corporate Communications’ and ‘Excellence in Engagement Through Social Media/Digital Channels – Under £50,000’ categories with our “Lift Up Your Everyday with...

Advertise to healthcare professionals with Springer Nature

Press Releases | July 11, 2023 | Springer Nature

Reach physicians and other HCPs with the publisher, Springer Nature

HealthScience communications consultancy wins King’s Award

Press Releases | July 11, 2023 | Oxford PharmaGenesis

Oxford PharmaGenesis, the global HealthScience communications consultancy, was honoured on Friday 7 July, by a visit from King Charles III’s representative in Oxfordshire, Lord-Lieutenant Marjorie Glasgow BEM.